| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 238.99M | — |
| Operating expense | — | — |
| Net income | 16.28M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XVIVO.ST returned +53.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +50.1% |
| 1 year | +53.7% |
| 5 years | -36.7% |
| 10 years | +281.0% |
| All-time high | kr 533.00 (Aug 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in XVIVO.ST would be worth today ›No. Xvivo Perfusion AB (publ) has not paid a dividend in the past 12 months.
Xvivo Perfusion AB (publ) is part of the Healthcare sector.
Xvivo Perfusion AB (publ) has a market cap of 8.82B SEK, based on the latest quote.
Xvivo Perfusion AB (publ) is scheduled to report earnings on Oct 22, 2026.
